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Intravenous itraconazole has been approved for second 
line therapy of invasive pulmonary aspergillosis. How- 
ever, little is known about its comparative antifungal 
efficacy against this disease in the state of persistent and 
profound neutropenia. We therefore investigated the 
pharmacokinetics and pharmacodynamics of intra- 
venous hydroxypropyl-beta-cyclodextrin itraconazole in 
a persistently neutropenic rabbit model of invasive 
pulmonary aspergillosis. 
Twenty-four hours following endotracheal inoculation 
with Aspergillus jumigatus, cohorts of 4 animals each 
received itraconazole at dosages ranging from 0.66 to 16 
mg/kg once daily as lo-minutes IV bolus for a total of 12 
days. Optimal plasma sampling was performed in each 
individual animal after the 5th dose to obtain pharma- 
cokinetic and pharmacodynamic parameters. Untreated 
animals and animals treated with standard amphotericin 
B deoxycholate (lmg/kg) served as controls. Responses 
to treatment were evaluated by survival and the residual 
fungal burden in lung tissue at autopsy. 
Intravenous itraconazole showed dose-dependent anti- 
fungal efficacy against invasive pulmonary aspergillosis. 
The relationship between dosage and residual fungal 
burden in lung tissue followed an inhibitory effect 
sigmoidal Emax function with an estimated ED50 of 7 
mg/kg. In comparison to untreated controls, treatment 
with dosages of 6.6 to 12 mg/kg resulted in a reduction 
of the residual fungal burden in lung tissue (p<O.OOOl) 
and improved survival (p ~0.001). Pharmacodynamic 
modeling revealed significant relationships between 
pharmacodynamic parameters, the residual fungal 
burden in lung tissue, and survival. Itraconazole was well 
tolerated without renal or hepatic laboratory abnor- 
malities. Acute dose-limiting neurological toxicity 
(seizures) occurred at 16mg/kg (2 animals). 
In conclusion, IV itraconazole displayed dose- 
dependent antifungal efficacy in a clinically relevant 
persistently neutropenic animal model of pulmonary 
aspergillosis. 
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Candida albicans is a polymorphic fungus that can 
switch between blastospores, pseudohyphae, and true 
hyphae. All three morphologic forms are frequently 
recovered from tissues of patients with disseminated 
candidiasis and are therefore important in the patho- 
genicity of C. albicans. Previously we cloned the 
Agglutinin-Like Sequence 1 (ALU) gene, which 
encodes a candidal cell surface protein. We demon- 
strated that Alsl protein (Alslp) is required for 
adherence to endothelial cells, and virulence in a mouse 
model of hematogenously disseminated candidiasis. 
To investigate the feasibility of using Alslp in vaccine 
strategies to protect against hematogenously dissemi- 
nated candidiasis, we studied the expression of ALSl in 
the three different morphologies of C. albicans. The 
expression of ALU was determined by Northern 
blotting, and confocal immunofluorescence microscopy 
using an ALSI specific probe and monoclonal antibody 
raised against the N-terminus of Alslp, respectively. 
RNA expression of ALSI was detected in all forms of 
C. albicans with maximal expression during lag phase of 
growth. Although Alslp was expressed during all 
polymorphic forms of C. albicans, localization of the 
protein on the cell surface was altered among these 
phases. Diffused staining was detected on the surface of 
blastospores. When cells were grown as pseudohyphae, 
Alslp expression was detected along the entire 
pseudohyphus. In contrast, in true hyphae, Alslp staining 
was most intense at the base of the emerging hyphae. 
The detection of Alslp expression on the cell surface 
during all three forms of C. albicans growth will prove 
to be beneficial in exploiting this protein to develop 
vaccine strategies against mucosal and disseminated 
candidiasis. 
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Introduction: Infections by filamentous fungi, parti- 
cularly Aspergillus spp., are increasing in incidence in 
immunocompromised patients and are associated with 
high morbidity and mortality. IL-15 is a Thl cytokine 
associated with the innate immune response, which has 
various enhancing effects on phagocytic function. IL-8 
is a potent chemokine and TNF-alpha has broad pro- 
inflammatory properties. We hypothesised that IL-15 
plays a role in modulation of the release of these two 
cytokines in response to Aspergillus spp. 
Methods: Polymorphonuclear leukocytes (PMNLs) 
were isolated by dextran sedimentation/ficoll centri- 
fugation from blood obtained from healthy adult donors. 
Following pre-treatment of PMNLs with or without 100 
rig/ml IL-15 for 22 hours, untreated and IL-15 treated 
PMNLs (1.5~ 10s/well) were incubated for 4 hours in 
HBSS, either unchallenged or challenged with hyphae of 
Aspergillus fumigatus, Aspergillus flavus or Verticillium 
nigrescens, a fungus of low pathogenicity, at E:T ratio 
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1O:l. The concentrations of IL-8 and TNF-alpha were 
then evaluated using ELISA. 
Results: A significant increase in IL-8 release by PMNLs 
was found in response to pre-treatment with IL-15 
(n=5, by Student paired t test, all comparisons P-cO.05) 
when unchallenged (from 460a105 to 964~229 pg/ml) 
and when challenged with either A. fumigatus (from 
1474_+334 to 3483_t777 pglml), or A. Jzavus (from 
14122366 to 2653k501 pg/ml) or I/: nigrescens (from 
1380+695 to 2190+760 pg/ml). In contrast, IL-15 did not 
have a significant effect on TNF-alpha release; however, 
very low levels of release were evident when challenged 
with the two Aspergillus spp. 
Conclusions: No significant increase in TNF-alpha 
release by human PMNLs occurs after IL-15 treatment. 
In contrast, IL-15 significantly enhances release of K-8, 
thus providing a mechanism for further recruitment 
of PMNLs in response to Aspergillus spp. and other 
filamentous fungi. 
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Objective: Filamentous fungi constitute an increasingly 
important cause of morbidity and mortality in immuno- 
compromised patients, who acquire them mainly 
through their respiratory system. The objective of this 
study was to determine the environmental fungal load 
(FL) in the air of high-risk hospital departments (depts), 
the drug susceptibility of the isolated fungi and the 
correlation of FL with nosocomial invasive fungal 
infections (IFI). 
Materials and methods: The study took place in a 1030- 
bed Greek tertiary hospital. From l-12/2000 and once 
per month, in Haematology (H), Paediatric Oncology 
(P) and Solid Organ Transplantation (T) departments, 
1.6 m3 of air were sampled. All samples were incubated 
at 37”C, colonies grown were then inoculated onto SDA 
plates and the isolated fungi were finally identified. 
Twelve A. fumigatus, 12 A. flavus and 12 A. niger isolates 
were randomly chosen and tested for MICs (no visual 
growth) of amphotericin B (AmB), itraconazole (ITC), 
voriconazole (VRC) and posaconazole (PSC) by 
NCCLS M38-P micro-method. During the sampling 
period, a surveillance of IF1 was also taking place. 
Results: ‘Ibe median of monthly FL measurements was 
8.7 cfu/m3 (range 1.2-28.3) in P, 16.5 (range 0.6-54.9) in 
T and 23.1 (range 15-44.9) in H. In all departments, FL 
was higher in summer and early autumn when the 
humidity and temperature were higher. FL was con- 
siderably higher in H where the building was old and 
renovation works were in progress in direct proximity 
with the ward, whereas it was much lower in P, situated 
in a new building. Aspergillus spp. dominated (64.9%) 
with niger,jlavus andfimigatus being the most prevalent 
isolates. Other Aspergillus spp. included nidulans and 
terreus; whereas, other filamentous fungi isolated were 
mainly zygomycetes (most commonly Rhizopus spp.) as 
well as dematiaceous fungi (Alternaria, Dreschlera and 
Curvularia spp.).The MIC90s for all the strains were 0.5 
mgll for PSC, 1 mg/l for AmB and VRC and 4 mg/l for 
ITC. Although there were variations in FL observed, no 
cases of probable or definite IF1 (EORTUMSG criteria) 
were recorded during the period of air surveillance in 
the 3 depts. 
Conclusions: A considerable number of filamentous 
fungi are found in the hospital environment mainly 
consisting of A. niger, A. flavus and A. fumigatus. 
Elevations of FL coincided with renovation activity as 
well as with humid and warm weather. While none of the 
three Aspergillus spp. possess unusual patterns of anti- 
fungal drug resistance, they are generally more susceptible 
to the newer azoles than to ITC. In our study, the height 
of FL does not correlate with the incidence of IFI. 
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Familial chronic mucocutaneous candidiasis (CMC) in 
combination with hypothyroidism (HT) may be a 
distinct syndrome. We report two unrelated families with 
CMC and HT. In the first family three out of four 
children of healthy, unrelated parents have CMC and 
acquired juvenile HT.The two oldest brothers developed 
HT at the age of 12 years and their sister at the age of 
four. A female cousin also has HT. In the other family 
one boy has CMC and developed HT, detected when he 
was 11 years old. His father, aunt and grandmother 
have CMC. The mucocutaneous involvement includes 
recurrent oral apthous ulcerations, cheilitis, oesophagitis 
and onychomycosis. They suffer from scaling blepharitis, 
hordeulum externum, seborrhoeic dermatitis, folliculitis, 
and one patient had widespread chronic, scaling 
erythematous dermatosis. Cultures of their lesions have 
yielded isolates of Candida albicans and Trichophyton 
species. They have swollen lips, tongue, buccal mucousa 
and eyelids (palpebral fissures). The siblings in family 
no.1 complain of chronic nasal stenosis with rhinitis and 
recurrent non-suppurative otitis. None of the affected 
has had severe infections requiring hospitalisation. 
Endocrinology: Thyroid antibodies were not detectable 
in the siblings in the first family, but their cousin had 
enhanced anti-TPO and anti-TG. The boy in the second 
